Applied BioCode is an in-vitro diagnostics (IVD) manufacturer that designs, develops, and commercializes cutting-edge multiplex panel tests.
View Our Products
Join Applied BioCode at the 2026 NILA Lab Leader Forum in Albuquerque, NM from March 4-6 to discover their high-throughput molecular diagnostic solutions.
Learn More
Applied BioCode announces FDA clearance of KingFisher™ Nucleic Acid Extraction for use with the BioCode® Respiratory Pathogen Panel (RPP)
Read Full Press Release
From clinical to research applications, our products and technology are designed to enhance your laboratory’s performance.
Easily mask and unmask pathogen targets for syndromic panels, offering flexibility to physican orders. By only running the necessary tests, our data masking capability maximizes insurance coverage according to MolDX standards.
BioCode® products are designed to meet your laboratory’s high-throughput syndromic panel needs. Process up to 188 patient samples in an 8-hour shift using our 96-well format molecular diagnostic system and syndromic panels capable of detecting up to 17 pathogens in a single test.
Eliminate the need for multiple instruments and increase sample delivery with high-throughput clinical diagnostic assays. More efficient compared to traditional methods, our technology streamlines your lab’s research and diagnosis tools, boosting efficiency and streamlining patient care.
Increase lab efficiency with a cost-efficient molecular diagnostic system that can test up to three different syndromic panels in parallel on a single run. Our technology automates PCR amplification, hybridization and target capture, and detection steps.
Applied BioCode Inc. is revolutionizing tools for research and clinical laboratories with its groundbreaking advancements in syndromic panel testing for infectious diseases.
Contact Us
